Senti Biosciences (SNTI) Institutional Ownership $3.43 +0.10 (+3.00%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$3.38 -0.05 (-1.46%) As of 03/28/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Senti Biosciences (NASDAQ:SNTI)CurrentInstitutional OwnershipPercentage25.73%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$228.00KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$17.47M Get SNTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Senti Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNTI Institutional Buying and Selling by Quarter Remove Ads Senti Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC51,600$181K0.0%N/A1.071% 2/11/2025 Virtu Financial LLC13,356$47K0.0%N/A0.277% 11/14/2024 NEA Management Company LLC442,615$1M0.1%-90.0%9.664% 11/7/2024 8VC GP I LLC253,755$573K0.8%-90.0%5.541% 10/31/2024 ARK Investment Management LLC176,666$399K0.0%-88.9%3.858% 7/26/2024 ARK Investment Management LLC1,585,772$438K0.0%-2.8%34.624% 2/12/2024 8VC GP I LLC2,537,558$1.68M1.7%N/A5.697% 1/17/2024 ARK Investment Management LLC1,969,860$1.30M0.0%+7.9%4.423% 10/27/2023 TD Asset Management Inc241,208$102K0.0%+88.4%0.542% 9/7/2023Triatomic Management LP300,533$188K0.2%+42.5%0.675% Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/10/2023 ARK Investment Management LLC1,829,815$1.15M0.0%-3.8%4.143% 5/3/2023Triatomic Management LP210,883$249K0.2%+39.0%0.477% 4/17/2023 ARK Investment Management LLC1,901,467$2.24M0.0%-1.3%4.305% 2/14/2023Triatomic Management LP151,675$214K0.2%+168.7%0.346% 2/13/2023 Artal Group S.A.55,555$78K0.0%-94.7%0.127% 2/7/2023 TD Asset Management Inc118,292$167K0.0%-12.3%0.270% 1/24/2023 ARK Investment Management LLC1,925,827$2.72M0.0%-7.8%4.391% 11/15/2022Triatomic Management LP56,454$123K0.1%N/A0.129% 11/7/2022 TD Asset Management Inc.134,892$285K0.0%+53.8%0.308% 11/3/2022 The Manufacturers Life Insurance Company117,707$248K0.0%N/A0.269% 10/17/2022 ARK Investment Management LLC2,087,696$4.53M0.0%N/A4.771% 8/11/2022 Artal Group S.A.1,055,555$2.07M0.1%N/A4.450% 8/8/2022 Allen Operations LLC21,443$42K0.0%N/A0.090% 8/4/2022 TD Asset Management Inc.87,696$172K0.0%N/A0.370% 7/29/2022Kingfisher Capital LLC113,163$222K0.1%N/A0.477% (Data available from 1/1/2016 forward)Remove Ads SNTI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNTI shares? During the previous two years, the following institutional investors and hedge funds held shares of Senti Biosciences shares: NEA Management Company LLC ($1M), 8VC GP I LLC ($573K), ARK Investment Management LLC ($399K), Triatomic Management LP ($188K), Renaissance Technologies LLC ($181K), and TD Asset Management Inc ($102K), and Virtu Financial LLC ($47K).Learn more on SNTI's institutional investors. What percentage of Senti Biosciences stock is owned by institutional investors? 25.73% of Senti Biosciences stock is owned by institutional investors. Learn more on SNTI's institutional investor holdings. Which institutional investors have been buying Senti Biosciences stock? The following institutional investors have purchased Senti Biosciences stock in the last 24 months: 8VC GP I LLC ($2.54M), Triatomic Management LP ($148.86K), ARK Investment Management LLC ($143.79K), TD Asset Management Inc ($113.17K), Renaissance Technologies LLC ($51.60K), and Virtu Financial LLC ($13.36K). How much institutional buying is happening at Senti Biosciences? Institutional investors have bought a total of 3,008,329 shares in the last 24 months. This purchase volume represents approximately $19.65M in transactions. Which Senti Biosciences major shareholders have been selling company stock? The following institutional investors have sold Senti Biosciences stock in the last 24 months: NEA Management Company LLC ($3.98M), 8VC GP I LLC ($2.28M), and ARK Investment Management LLC ($1.55M). How much institutional selling is happening at Senti Biosciences? Institutional investors have sold a total of 7,817,607 shares in the last 24 months. This volume of shares sold represents approximately $18.21M in transactions. Related Companies Alto Neuroscience Major Shareholders Skye Bioscience Major Shareholders IGM Biosciences Major Shareholders Aligos Therapeutics Major Shareholders Adaptimmune Therapeutics Major Shareholders Entera Bio Major Shareholders I-Mab Major Shareholders ESSA Pharma Major Shareholders Scilex Major Shareholders Ikena Oncology Major Shareholders This page (NASDAQ:SNTI) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNTI Stock Free SNTI Stock Alerts